Skip to main content
. 2023 Oct 30;11(11):2935. doi: 10.3390/biomedicines11112935

Figure 3.

Figure 3

Subgroup analysis of cumulative probability of remaining severe dementia free in APOE ε4 non-carriers and carriers. (a) Subgroup analysis of outcomes in APOE ε4 carriers; (b) Subgroup analysis of outcomes in APOE ε4 non-carriers.